Bank Of Montreal Ocular Therapeutix, Inc Transaction History

Bank Of Montreal

  • $214 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 02, 2023
BUY
$4.6 - $7.64 $834,941 - $1.39 Million
181,509 New
181,509 $936,000
Q2 2022

Aug 11, 2022
BUY
$3.01 - $5.22 $903,776 - $1.57 Million
300,258 Added 142.34%
511,195 $2.16 Million
Q1 2022

May 12, 2022
BUY
$4.83 - $7.35 $1.02 Million - $1.55 Million
210,937 New
210,937 $1.08 Million

Others Institutions Holding OCUL

# of Institutions
173
Shares Held
136M
Call Options Held
150K
Put Options Held
225K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $617M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email